Abstract:Insulin-producing pancreatic β cells play a crucial role in the regulation of glucose homeostasis, and their failure is a key event for diabetes development. Prolonged exposure to palmitate in the presence of elevated glucose levels, termed gluco-lipotoxicity, is known to induce β cell apoptosis. Autophagy has been proposed to be regulated by gluco-lipotoxicity in order to favor β cell survival. However, the role of palmitate metabolism in gluco-lipotoxcity-induced autophagy is presently unknown. We therefore treated INS-1 cells for 6 and 24 h with palmitate in the presence of low and high glucose concentrations and then monitored autophagy. Gluco-lipotoxicity induces accumulation of LC3-II levels in INS-1 at 6 h which returns to basal levels at 24 h. Using the RFP-GFP-LC3 probe, gluco-lipotoxicity increased both autophagosomes and autolysosmes structures, reflecting early stimulation of an autophagy flux. Triacsin C, a potent inhibitor of the long fatty acid acetyl-coA synthase, completely prevents LC3-II formation and recruitment to autophagosomes, suggesting that autophagic response requires palmitate metabolism. In contrast, etomoxir and bromo-palmitate, inhibitors of fatty acid mitochondrial β-oxidation, are unable to prevent gluco-lipotoxicity-induced LC3-II accumulation and recruitment to autophagosomes. Moreover, bromo-palmitate and etomoxir potentiate palmitate autophagic response. Even if gluco-lipotoxicity raised ceramide levels in INS-1 cells, ceramide synthase 4 overexpression does not potentiate LC3-II accumulation. Gluco-lipotoxicity also still stimulates an autophagic flux in the presence of an ER stress repressor. Finally, selective inhibition of sphingosine kinase 1 (SphK1) activity precludes gluco-lipotoxicity to induce LC3-II accumulation. Moreover, SphK1 overexpression potentiates autophagic flux induced by gluco-lipotxicity. Altogether, our results indicate that early activation of autophagy by gluco-lipotoxicity is mediated by SphK1, which plays a protective role in β cells.

Sphingosine Kinase 1 Protects Hepatocytes from Lipotoxicity Via Down-regulation of IRE1α Protein Expression

Sphingosine Kinase 1 Knockout Alleviates Hepatic Ischemia/reperfusion Injury by Attenuating Inflammation and Oxidative Stress in Mice.

Deletion of Sphingosine Kinase 1 Ameliorates Hepatic Steatosis in Diet-Induced Obese Mice: Role of PPARγ.

Loss of Sphingosine Kinase 1 Predisposes to the Onset of Diabetes Via Promoting Pancreatic Β‐cell Death in Diet‐induced Obese Mice

Sphingosine kinase 1 inhibition improves lipopolysaccharide/D-galactosamine-induced acute liver failure by inhibiting mitogen-activated protein kinases pathway.

Inhibition of SphK1 expression by β-arrestin1/2

Sphingosine-1-phosphate Attenuates Endoplasmic Reticulum Stress-induced Cardiomyocyte Apoptosis Through Sphingosine-1-phosphate Receptor 1

Sphingosine kinase 1 aggravates liver fibrosis by mediating macrophage recruitment and polarization.

Regulation of hepatic insulin signaling and glucose homeostasis by sphingosine kinase 2

Role of Sphingosine Kinase 1 in Gluco-lipotoxicity-Induced Early Activation of Autophagy in INS-1 Pancreatic β Cells

Sphingosylphosphorylcholine Protects Cardiomyocytes Against Ischemic Apoptosis Via Lipid Raft/pten/akt1/mtor Mediated Autophagy

Sphingosine kinase 1 is involved in triglyceride breakdown by maintaining lysosomal integrity in brown adipocytes

Generation of sphingosine-1-phosphate by sphingosine kinase 1 protects nonalcoholic fatty liver from ischemia/reperfusion injury through alleviating reactive oxygen species production in hepatocytes

Deletion of Sphingosine Kinase 1 Inhibits Liver Tumorigenesis in Diethylnitrosamine-Treated Mice.

The impacts of SphK1 on inflammatory response and oxidative stress in LPS-induced ALI/ARDS

IRE1α prevents hepatic steatosis by processing and promoting the degradation of select microRNAs

Sphingosine kinase 1 regulates HMGB1 translocation by directly interacting with calcium/calmodulin protein kinase II-δ in sepsis-associated liver injury

IRE1α aggravates ischemia reperfusion injury of fatty liver by regulating phenotypic transformation of kupffer cells

An inducible sphingosine kinase 1 in hepatic stellate cells potentiates liver fibrosis

Sphingosine kinase 1 regulates HMGB1 translocation by directly interacting with calcium/calmodulin protein kinase II- in sepsis-associated liver injury

Conjugated bile acid-activated S1P receptor 2 is a key regulator of sphingosine kinase 2 and hepatic gene expression.